Oemrawsingh, Arvind
van Leeuwen, Nikki
Venema, Esmee
Limburg, Martien
de Leeuw, Frank-Erik
Wijffels, Markus P.
de Groot, Aafke J.
Hilkens, Pieter H. E.
Hazelzet, Jan A.
Dippel, Diederik W. J.
Bakker, Carla H.
Voogdt-Pruis, Helene R.
Lingsma, Hester F.
Funding for this research was provided by:
Stichting Kwaliteitsgelden Medisch Specialisten (-)
Achmea (-)
Article History
Received: 31 May 2019
Accepted: 8 November 2019
First Online: 5 December 2019
Ethics approval and consent to participate
: Formal ethical approval was not required as primary data were already collected and part of a quality registry. An ‘opt-out’ procedure was put in place, in which patients were informed about the quality registry and had the option to refuse their data being used.
: Not applicable.
: - Authors AO and JH are supported by a grant from the Federation of Dutch University Medical Centers (NFU).- Author DD reports grants and other from Stryker European Operations BV, grants from Penumbra Inc., grants from Medtronic, grants from Dutch Heart Foundation, grants from Brain Foundation Netherlands, grants from ZON MW () and grants from Thrombolytic Science, LLC, outside the submitted work.- Remaining authors declare no competing interests.- This study was a cooperation of 8 parties: Stroke Knowledge Network Netherlands, Achmea Holding N.V., Netherlands Federation of University Medical Centres (NFU), Dutch Association for Neurology (NVN), Netherlands Society of Rehabilitation Medicine (VRA), Dutch Association of Elderly Care Physicians and Social Geriatricians (Verenso), The Dutch College of General Practitioners (NHG), Dutch Institute for Clinical Auditing (DICA), National Health Care Institute (ZN).